{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:09:16Z","timestamp":1759972156928,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.braindev.2023.06.002","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T14:34:17Z","timestamp":1686839657000},"page":"476-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to letter to the editor \u201cRegarding nusinersen and other therapeutic strategies for improved motor function\u201d"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-4813","authenticated-orcid":false,"given":"Yuko","family":"Shimizu-Motohashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Komaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2023.06.002_b0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.braindev.2023.03.003","article-title":"Treating neurodegenerative disease: nusinersen and other therapeutic strategies for improved motor function","volume":"45","author":"Pashin","year":"2023","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2023.06.002_b0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.braindev.2022.11.002","article-title":"Muscle impairment in MRI affect variability in treatment response to nusinersen in patients with spinal muscular atrophy type 2 and 3: a retrospective cohort study","volume":"45","author":"Shimizu-Motohashi","year":"2023","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2023.06.002_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105488","article-title":"Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic \u0394 7SMA mice","volume":"159","author":"Kray","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.braindev.2023.06.002_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2022.04.006","article-title":"Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: a systematic review of real-world study data","volume":"39","author":"Erdos","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2023.06.002_b0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/mus.27375","article-title":"Combination therapy with onasemnogene and risdiplam in spinal muscular atrophy type 1","volume":"64","author":"Oechsel","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.braindev.2023.06.002_b0030","article-title":"A Patient-centered evaluation of meaningful change on the 32-item motor function measure in spinal muscular atrophy using qualitative and quantitative data","volume":"12","author":"Duong","year":"2021","journal-title":"Front Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760423001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760423001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:51:30Z","timestamp":1759953090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760423001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0387760423001031"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2023.06.002","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply to letter to the editor \u201cRegarding nusinersen and other therapeutic strategies for improved motor function\u201d","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2023.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of The Japanese Society of Child Neurology. All rights reserved.","name":"copyright","label":"Copyright"}]}}